Neuropsychological profile of patients with infectious disease: characterization and comparison of patients with HIV, HTLV, and HCV

Imagem de Miniatura
Arquivos
art_GASCON_Neuropsychological_profile_of_patients_with_infectious_disease_characterization_2023.PDF (1.1 MB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
OLIVEIRA, Giovana S. de
LAURENCE, Paulo Guirro
OLIVEIRA, Augusto Cesar Penalva de
SMID, Jerusa
MACEDO, Elizeu Coutinho
Citação
JOURNAL OF NEUROVIROLOGY, v.29, n.1, p.27-34, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Understanding the effect of the HIV, HTLV-1, and HCV viruses on cognitive aspects can help in the better characterization of dementia, as well as the best conducts to be suitable for rehabilitation. Thus, the present study aimed to characterize and compare the neuropsychological profile of 3 groups of patients with infectious diseases: HIV, HTLV, and HCV. The results of neuropsychological assessments and depression assessment of 325 people treated at a referral hospital for infectious dis-eases were analyzed, being 120 HIV carriers (74 (61.7%) men) with an average age of 47.5 years (SD = 10.3), 65 patients with HTLV-1 (16 (24.6%) men) with a mean age of 49.9 years (SD = 12.9), and 87 HCV patients (47 (54%) men) with a mean age of 55.5 years (SD = 11.2). In addition, 54 people (26 (48.1%) men) with negative serology who made up the con-trol group were evaluated. The results of the statistical evaluation of the sociodemographic factors of the four groups (HIV, HTLV-1, HCV, and control) showed that in addition to age, schooling was a significant factor among them and may have a strong influence on the performance of cognitive tests. The HTLV-1 group had the lowest neurocognitive performance and also the highest rate of depressive symptoms.
Palavras-chave
Neuropsychology, Cognitive assessment, HIV, HCV, HTLV
URI
https://observatorio.fm.usp.br/handle/OPI/53886
Referências
  1. Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b
  2. Ben-Shachar M. S., 2020, J OPEN SOURCE SOFTW, V5, DOI [10.21105/joss.02815, DOI 10.21105/JOSS.02815, 10/ghq8sk]
  3. Carneiro-Proietti Anna Bárbara F., 2002, Rev. Soc. Bras. Med. Trop., V35, P499, DOI 10.1590/S0037-86822002000500013
  4. Cartier R Luis, 2009, Rev. chil. neuro-psiquiatr., V47, P50
  5. Champs Ana Paula Silva, 2013, Dement. neuropsychol., V7, P439, DOI 10.1590/S1980-57642013DN74000014
  6. Chandra PS, 2005, INDIAN J MED RES, V121, P451
  7. CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562
  8. Christo PP, 2005, ARQ NEURO-PSIQUIAT, V63, P907, DOI 10.1590/S0004-282X2005000600001
  9. Christo PP, 2014, NEUROPSICOLOGIA
  10. Cruz Neves A, 2006, ACTA MEDICA PORT, V19, P21
  11. Dalgalarrondo P, 2019, PSICOPATOLOGIA SEMIO
  12. de Almeida SM, 2018, J NEUROVIROL, V24, P339, DOI 10.1007/s13365-018-0617-5
  13. de Oliveira JF, 2006, REV SOC BRAS MED TRO, V39, P146, DOI 10.1590/S0037-86822006000200002
  14. El-Serag HB, 2002, GASTROENTEROLOGY, V123, P476, DOI 10.1053/gast.2002.34750
  15. El-Zayadi AR, 2009, WORLD J GASTROENTERO, V15, P4993, DOI 10.3748/wjg.15.4993
  16. Escosteguy CC, 2004, REV SAUDE PUBL, V38, P657, DOI 10.1590/S0034-89102004000500007
  17. Romanelli LCF, 2010, REV ASSOC MED BRAS, V56, P340, DOI 10.1590/S0104-42302010000300021
  18. Filley CM, 1998, NEUROLOGY, V50, P1535, DOI 10.1212/WNL.50.6.1535
  19. Forton DA, 2005, AIDS, V19, pS53, DOI 10.1097/01.aids.0000192071.72948.77
  20. Forton DM, 2003, J HEPATOL, V39, P272, DOI 10.1016/S0168-8278(03)00268-X
  21. Forton DM, 2003, J VIRAL HEPATITIS, V10, P81, DOI 10.1046/j.1365-2893.2003.00416.x
  22. Gascon MRP, 2017, J NEUROL SCI, V377, P185, DOI 10.1016/j.jns.2017.04.019
  23. Gascon MRP, 2015, THESIS SP SESSP CTDP
  24. Gorestein C, 2012, BDI 2 INVENTARIO BEC
  25. Hothorn T., 2008, MULTCOMP SIMULTANEOU
  26. KATZMAN R, 1993, NEUROLOGY, V43, P13, DOI 10.1212/WNL.43.1_Part_1.13
  27. Lima MCC, 2017, THESIS U SAO PAULO S
  28. McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053
  29. Mendes GB, 2014, INT J INFECT DIS, V25, P1, DOI 10.1016/j.ijid.2014.03.1374
  30. Nightingale S, 2014, LANCET NEUROL, V13, P1139, DOI 10.1016/S1474-4422(14)70137-1
  31. Nordon DG, 2009, REV FM CIENC SOROCAB, V11, P5
  32. Oliveira MS, 2017, FIGURAS COMPLEXAS RE
  33. OSAME M, 1986, LANCET, V1, P1031
  34. Gascon MRP, 2020, ARQ NEURO-PSIQUIAT, V78, P342, DOI [10.1590/0004-282X20200022, 10.1590/0004-282x20200022., 10.1590/0004-282x20200022]
  35. Gascon MRP, 2018, AIDS PATIENT CARE ST, V32, P1, DOI 10.1089/apc.2017.0202
  36. Quarantini LC, 2009, J MED VIROL, V81, P1184, DOI 10.1002/jmv.21508
  37. R Development Core Team, 2008, R LANG ENV STAT COMP
  38. Ribeiro AM, 2006, TRATADO GERIATRIA GE
  39. Richardson JL, 2005, AIDS, V19, P1659, DOI 10.1097/01.aids.0000186824.53359.62
  40. Rifai Muhamad Aly, 2010, Prim Care Companion J Clin Psychiatry, V12, DOI 10.4088/PCC.09r00877whi
  41. Romanelli LCF, 2011, REV CIE MED PERNAMBU, V7
  42. RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219
  43. Silva MTT, 2003, J NEUROL NEUROSUR PS, V74, P1085, DOI 10.1136/jnnp.74.8.1085
  44. Souza ARM, 2009, JORNAL BRASILEIRO DO, V21, P163
  45. Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd
  46. Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8
  47. Troncoso FT, 2015, REV SOC BRAS MED TRO, V48, P390, DOI 10.1590/0037-8682-0034-2015
  48. Wechsler, 2004, WAIS

Coleções
Artigos e Materiais de Revistas Científicas - FM/MDT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/56
Artigos e Materiais de Revistas Científicas - LIM/60
Artigos e Materiais de Revistas Científicas - ODS/03